Literature DB >> 17682895

Cell therapy for tendon repair in horses: an experimental study.

A Crovace1, L Lacitignola, R De Siena, G Rossi, E Francioso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17682895     DOI： 10.1007/s11259-007-0047-y

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN： 0165-7380            Impact factor:   2.459


× No keyword cloud information.
  5 in total

1.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

2.  Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?

Authors:  R K W Smith; P M Webbon
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

3.  Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy.

Authors:  Alex Blatt; Gad Cotter; Marina Leitman; Ricardo Krakover; Edo Kaluski; Olga Milo-Cotter; Igor B Resnick; Simcha Samuel; David Gozal; Zvi Vered; Shimon Slavin; Michael Y Shapira
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

Review 4.  Tendon injury and tendinopathy: healing and repair.

Authors:  Pankaj Sharma; Nicola Maffulli
Journal:  J Bone Joint Surg Am       Date:  2005-01       Impact factor: 5.284

5.  Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.

Authors:  Seung-Woo Cho; Hee Jung Park; Ju Hee Ryu; Soo Hyun Kim; Young Ha Kim; Cha Yong Choi; Min-Jae Lee; Jong-Sung Kim; In-Sung Jang; Dong-Ik Kim; Byung-Soo Kim
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479
  5 in total
  17 in total

1.  Expression of scleraxis and tenascin C in equine adipose and umbilical cord blood derived stem cells is dependent upon substrata and FGF supplementation.

Authors:  Sarah A Reed; Sally E Johnson
Journal:  Cytotechnology       Date:  2013-01-09       Impact factor: 2.058

Review 2.  Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?

Authors:  Jan H Spaas; Deborah J Guest; Gerlinde R Van de Walle
Journal:  Sports Med       Date:  2012-10-01       Impact factor: 11.136

3.  Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo.

Authors:  M Del Bue; S Riccò; R Ramoni; V Conti; G Gnudi; S Grolli
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

4.  The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?

Authors:  Ciro Tetta; Anna Lange Consiglio; Stefania Bruno; Emanuele Tetta; Emanuele Gatti; Miryana Dobreva; Fausto Cremonesi; Giovanni Camussi
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

Review 5.  Concepts for the clinical use of stem cells in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

Review 6.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

7.  Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials.

Authors:  Deana S Shenaq; Farbod Rastegar; Djuro Petkovic; Bing-Qiang Zhang; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Qing Luo; Qiong Shi; Eric R Wagner; Enyi Huang; Yanhong Gao; Jian-Li Gao; Stephanie H Kim; Ke Yang; Yang Bi; Yuxi Su; Gaohui Zhu; Jinyong Luo; Xiaoji Luo; Jiaqiang Qin; Russell R Reid; Hue H Luu; Rex C Haydon; Tong-Chuan He
Journal:  Stem Cells Int       Date:  2010-12-16       Impact factor: 5.443

8.  Stem cell applications in tendon disorders: a clinical perspective.

Authors:  Mark Young
Journal:  Stem Cells Int       Date:  2012-01-29       Impact factor: 5.443

Review 9.  Biologics for tendon repair.

Authors:  Denitsa Docheva; Sebastian A Müller; Martin Majewski; Christopher H Evans
Journal:  Adv Drug Deliv Rev       Date:  2014-11-21       Impact factor: 15.470

10.  Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.

Authors:  Roger Kenneth Whealands Smith; Natalie Jayne Werling; Stephanie Georgina Dakin; Rafiqul Alam; Allen E Goodship; Jayesh Dudhia
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.